Efficacy of low-dose spironolactone in subjects with resistant hypertension.

Nishizaka MK, Zaman MA, Calhoun DA. Efficacy of low-dose spironolactone in subjects with resistant hypertension. Am J Hypertens. 2003 Nov; 16(11 Pt 1):925-30.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Aldosterone
Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents
Diuretics
Drug Therapy, Combination
Female
Follow-Up Studies
Humans
Hypertension
Male
Middle Aged
Renin
Spironolactone
Treatment Outcome

authors with profiles

David Calhoun

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support